Cell- and Tissue-Based Therapy
"Cell- and Tissue-Based Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Therapies that involve the TRANSPLANTATION of CELLS or TISSUES developed for the purpose of restoring the function of diseased or dysfunctional cells or tissues.
| Descriptor ID |
D064987
|
| MeSH Number(s) |
E02.095.147
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cell- and Tissue-Based Therapy".
Below are MeSH descriptors whose meaning is more specific than "Cell- and Tissue-Based Therapy".
This graph shows the total number of publications written about "Cell- and Tissue-Based Therapy" by people in this website by year, and whether "Cell- and Tissue-Based Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2013 | 0 | 2 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 17 | 10 | 27 |
| 2018 | 17 | 7 | 24 |
| 2019 | 2 | 4 | 6 |
| 2020 | 9 | 2 | 11 |
| 2021 | 2 | 3 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Cell- and Tissue-Based Therapy" by people in Profiles.
-
Clinical experience of coronavirus disease 2019 in hematopoietic cell transplant and chimeric antigen receptor T-cell recipients. Curr Opin Hematol. 2021 11 01; 28(6):394-400.
-
IL-6: from arthritis to CAR-T-cell therapy and COVID-19. Int Immunol. 2021 09 25; 33(10):515-519.
-
Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study. Clin Infect Dis. 2021 08 02; 73(3):e815-e821.
-
Regulation of Inflammatory Cytokine Storms by Mesenchymal Stem Cells. Front Immunol. 2021; 12:726909.
-
Cell therapy in patients with COVID-19 using Wharton's jelly mesenchymal stem cells: a phase 1 clinical trial. Stem Cell Res Ther. 2021 07 16; 12(1):410.
-
Mesenchymal stem cells: ideal seeds for treating diseases. Hum Cell. 2021 Nov; 34(6):1585-1600.
-
Is There a Role for Cellular Therapy in Chronic Lymphocytic Leukemia? Cancer J. 2021 Jul-Aug 01; 27(4):297-305.
-
Next-Generation Implementation of Chimeric Antigen Receptor T-Cell Therapy Using Digital Health. JCO Clin Cancer Inform. 2021 06; 5:668-678.
-
Immunomodulatory extracellular vesicles: an alternative to cell therapy for COVID-19. Expert Opin Biol Ther. 2021 12; 21(12):1551-1560.
-
Treatment of COVID-19 by stage: any space left for mesenchymal stem cell therapy? Regen Med. 2021 05; 16(5):477-494.